[1] ZHENG Rongshou, SUN Kexin, ZHANG Siwei et al. Report of cancer epidemiology in China, 2015[J]. Chinese Journal of Oncology, 41, 19-28(2019).

[2] Tang Q, Çağlayan M. The scaffold protein XRCC1 stabilizes the formation of polβ/gap DNA and ligase Ⅲα/nick DNA complexes in base excision repair[J]. Journal of Biological Chemistry, 297, 101025(2021).

[3] Gong L, Luo M, Sun R H et al. Significant association between XRCC1 expression and its rs25487 polymorphism and radiotherapy-related cancer prognosis[J]. Frontiers in Oncology, 11, 654784(2021).

[4] Thakur N, Yim K, Abdul-Ghafar J et al. High poly(ADP-ribose) polymerase expression does relate to poor survival in solid cancers: a systematic review and meta-analysis[J]. Cancers, 13, 5594(2021).

[5] Zhang Y W, Dong S W, Xu R P et al. Prognostic and predictive role of COX-2, XRCC1 and RASSF1 expression in patients with esophageal squamous cell carcinoma receiving radiotherapy[J]. Oncology Letters, 13, 2549-2556(2017).

[6] Niu Y J, Zhang X, Zheng Y X et al. XRCC1 deficiency increased the DNA damage induced by γ-ray in HepG2 cell: involvement of DSB repair and cell cycle arrest[J]. Environmental Toxicology and Pharmacology, 36, 311-319(2013).

[7] Wu Z C, Miao X Y, Zhang Y F et al. XRCC1 is a promising predictive biomarker and facilitates chemo-resistance in gallbladder cancer[J]. Frontiers in Molecular Biosciences, 7, 70(2020).

[8] Hastak K, Bhutra S, Parry R et al. Poly (ADP-ribose) polymerase inhibitor, an effective radiosensitizer in lung and pancreatic cancers[J]. Oncotarget, 8, 26344-26355(2017).

[9] Feng F Y, Speers C, Liu M L et al. Targeted radiosensitization with PARP1 inhibition: optimization of therapy and identification of biomarkers of response in breast cancer[J]. Breast Cancer Research and Treatment, 147, 81-94(2014).

[10] Mueller S, Bhargava S, Molinaro A M et al. Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma[J]. Anticancer Research, 33, 755-762(2013).

[11] Demin A A, Hirota K, Tsuda M et al. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair[J]. Molecular Cell, 81, 3018-3030.e5(2021).

[12] Rashid I, Hammel M, Sverzhinsky A et al. Direct interaction of DNA repair protein tyrosyl DNA phosphodiesterase 1 and the DNA ligase Ⅲ catalytic domain is regulated by phosphorylation of its flexible N-terminus[J]. Journal of Biological Chemistry, 297, 100921(2021).

[13] Vasil'eva I A, Moor N A, Lavrik O I. Effect of human XRCC1 protein oxidation on the functional activity of its complexes with the key enzymes of DNA base excision repair[J]. Biochemistry (Moscow), 85, 288-299(2020).

[14] Wang W M, Yang J J, Yu Y et al. Expression of JWA and XRCC1 as prognostic markers for gastric cancer recurrence[J]. International Journal of Clinical and Experimental Pathology, 13, 3120-3127(2020).

[15] Pascal J M. The comings and goings of PARP-1 in response to DNA damage[J]. DNA Repair, 71, 177-182(2018).

[16] Hanzlikova H, Kalasova I, Demin A A et al. The importance of poly(ADP-ribose) polymerase as a sensor of unligated Okazaki fragments during DNA replication[J]. Molecular Cell, 71, 319-331.e3(2018).

[17] Abbotts R, D M Ⅲ Wilson. Coordination of DNA single strand break repair[J]. Free Radical Biology and Medicine, 107, 228-244(2017).

[18] Tallis M, Morra R, Barkauskaite E et al. Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response[J]. Chromosoma, 123, 79-90(2014).

[19] Breslin C, Hornyak P, Ridley A et al. The XRCC1 phosphate-binding pocket binds poly (ADP-ribose) and is required for XRCC1 function[J]. Nucleic Acids Research, 43, 6934-6944(2015).

[20] Kumar A, Reed A J, Zahurancik W J et al. Interlocking activities of DNA polymerase β in the base excision repair pathway[J]. Proceedings of the National Academy of Sciences of the United States of America, 119, e2118940119(2022).

[21] Polo L M, Xu Y Q, Hornyak P et al. Efficient single-strand break repair requires binding to both poly(ADP-ribose) and DNA by the central BRCT domain of XRCC1[J]. Cell Reports, 26, 573-581.e5(2019).

[22] Lavrik O I. PARPs' impact on base excision DNA repair[J]. DNA Repair, 93, 102911(2020).

[23] Ali R, Alabdullah M, Alblihy A et al. PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers[J]. Cancer Letters, 469, 124-133(2020).

[24] D'Andrea A D. Mechanisms of PARP inhibitor sensitivity and resistance[J]. DNA Repair, 71, 172-176(2018).

[25] Ferrara R, Simionato F, Ciccarese C et al. The development of PARP as a successful target for cancer therapy[J]. Expert Review of Anticancer Therapy, 18, 161-175(2018).

[26] Fong P C, Boss D S, Yap T A et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers[J]. The New England Journal of Medicine, 361, 123-134(2009).

[27] Nickoloff J A, Sharma N, Taylor L. Clustered DNA double-strand breaks: biological effects and relevance to cancer radiotherapy[J]. Genes, 11, 99(2020).

[28] Reber J M, Božić-Petković J, Lippmann M et al. PARP1 and XRCC1 exhibit a reciprocal relationship in genotoxic stress response[J]. Cell Biology and Toxicology, 1-20(2022).

[29] Prasad C B, Prasad S B, Yadav S S et al. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property[J]. Scientific Reports, 7, 12876(2017).

[30] Cho E A, Juhnn Y S. The cAMP signaling system inhibits the repair of γ-ray-induced DNA damage by promoting Epac1-mediated proteasomal degradation of XRCC1 protein in human lung cancer cells[J]. Biochemical and Biophysical Research Communications, 422, 256-262(2012).

[31] Mei P J, Bai J, Miao F A et al. Relationship between expression of XRCC1 and tumor proliferation, migration, invasion, and angiogenesis in glioma[J]. Investigational New Drugs, 37, 646-657(2019).

[32] Rezapoor S, Shirazi A, Abbasi S et al. Modulation of radiation-induced base excision repair pathway gene expression by melatonin[J]. Journal of Medical Physics, 42, 245-250(2017).

[33] Toulany M, Dittmann K, Fehrenbacher B et al. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro[J]. DNA Repair, 7, 1746-1756(2008).

[34] Huang R X, Zhou P K. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer[J]. Signal Transduction and Targeted Therapy, 5, 60(2020).